Fig. 1From: Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseasesFlowchart of patient selection process. Women with cancer or autoimmune disease consulted on fertility preservation (FP) options at Keio University Hospital during January 2018 and December 2021 were enrolledBack to article page